Planipart

Planipart - General Information

A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. [PubChem]

Pharmacology of Planipart

Planipart is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. Although approved for use in some countries, as of fall, 2006, clenbuterol is not an ingredient of any therapeutic drug approved by the U.S. Food and Drug Administration.

Additional information about Planipart

Planipart Indication: Used as a bronchodilator in the treatment of asthma patients.
Mechanism Of Action: Not Available
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Clenbuterol
Synonyms: Clenbuterolum [inn-latin]
Drug Category: Adrenergic beta-Agonists; Bronchodilator Agents; Sympathomimetics
Drug Type: Small Molecule; Approved

Other Brand Names containing Clenbuterol: Planipart;
Absorption: 89-98% orally
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: 36-39 hours
Dosage Forms of Planipart: Not Available
Chemical IUPAC Name: 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol
Chemical Formula: C12H18Cl2N2O
Clenbuterol on Wikipedia: https://en.wikipedia.org/wiki/Clenbuterol
Organisms Affected: Humans and other mammals